ONCO Stock Analysis: Buy, Sell, or Hold?
ONCO - Onconetix, Inc. Common Stock
$0.63
0.01 (2.37%)
▲
5d:
-4.45%
30d:
-24.18%
90d:
-45.02%
HOLD
LOW Confidence
Analysis Updated: Aug 31, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When ONCO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ONCO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ONCO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ONCO is currently trading at $0.63, which is considered oversold relative to its 30-day fair value range of $0.67 to $0.89.
Technical Outlook: Technically, ONCO is showing sideways momentum. Immediate support is located at $0.59, while resistance sits at $0.80.
Market Sentiment: ONCO scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $9.00 (+1335.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ONCO is showing sideways momentum. Immediate support is located at $0.59, while resistance sits at $0.80.
Market Sentiment: ONCO scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $9.00 (+1335.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.67 -
$0.89
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (63/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1335.9% below Wall St target ($9.00)
- CAUTION: Bottoming setup, but lagging the sector by 25% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$0.67 -
$0.89
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.59
Resistance Level
$0.80
Current Trend
Sideways
Technical data as of
Aug 31, 2026
Fundamental Context
Wall Street Target
$9.00
(+1335.9%)
Revenue Growth (YoY)
-83.9%
Share & Embed Analysis
Last updated: August 31, 2026 8:12 PM ET
Data refreshes hourly during market hours. Next update: 9:12 PM
Data refreshes hourly during market hours. Next update: 9:12 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ONCO showing a specific setup today?
Insider Activity (6 Months)
3
Buys
3
Sells
0
Net
NEUTRAL
Recent Transactions
Financial Lp Hrt
SELL
49710 shares
2026-04-21
Financial Lp Hrt
SELL
94462 shares
2026-04-20
Financial Lp Hrt
BUY
34636 shares
2026-04-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 52 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 46 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 42 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$127 | 52 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 49 HOLD |
